[REGN] YoY Annual Result on 31-Dec-2015 [#FY]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
11-Feb-2016
Financial Year
2015
Quarter
31-Dec-2015 [#FY]
Profit Trend
YoY- 82.74%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Annual Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 6,710,800 5,872,227 4,860,427 4,103,728 2,819,557 2,104,745 1,378,477 30.16%
PBT 2,553,500 2,078,511 1,329,815 1,225,097 775,747 713,360 414,421 35.38%
Tax 109,100 880,000 434,293 589,041 427,673 288,998 -335,848 -
NP 2,444,400 1,198,511 895,522 636,056 348,074 424,362 750,269 21.74%
Tax Rate -4.27% -42.34% -32.66% -48.08% -55.13% -40.51% 81.04% -
Total Cost 4,266,400 4,673,716 3,964,905 3,467,672 2,471,483 1,680,383 628,208 37.59%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin 36.42 20.41 18.42 15.50 12.34 20.16 54.43 -6.47%
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS 21.29 11.27 8.55 6.17 3.36 4.23 7.92 17.90%
EPS Diluted 21.29 10.34 7.70 5.52 2.98 3.72 6.75 21.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.